Key Account Manager

Why Cor Medix Therapeutics?

If you are interested in joining an entrepreneurial team, focused on bringing life-saving therapies to market for critical unmet medical needs, consider applying for a role at Cor Medix Therapeutics. The culture at Cor Medix Therapeutics is patient-centered where we feel a sense of urgency to solve some of the most pressing issues in hospital-based healthcare.

Cor Medix Therapeutics's greatest asset is our people. We have a deeply experienced team and continue to bring on some of the brightest talent that can problem solve and execute with high-precision. We are passionate about the work we do and how we do it. We believe in building highly engaged teams that exude integrity, open communication, and innovation. We believe in fostering each employee to reach their highest potential by offering an inclusive environment, opportunities to challenge yourself and grow, and a community of purpose.

We expect that everyone here brings their best selves to work and together, our singular efforts culminate into profound and meaningful breakthroughs.

Company

Description:

Cor Medix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. Cor Medix is commercializing Defen Cath (taurolidine and heparin) for the prevention of catheter-related bloodstream infections in adult patients undergoing hemodialysis via a central venous catheter. Following its August 2025 acquisition of Melinta Therapeutics LLC, Cor Medix is also commercializing a portfolio of anti-infective products, including MINOCIN (minocycline), REZZAYO (rezafungin), VABOMERE (meropenem and vaborbactam), ORBACTIV (oritavancin), BAXDELA (delafloxacin), and KIMYRSA (oritavancin), as well as TOPROL-XL (metoprolol succinate).

Cor Medix has ongoing clinical studies for Defen Cath in Total Parenteral Nutrition and Pediatric patient populations and also intends to develop Defen Cath as a catheter lock solution for use in other patient populations. REZZAYO is currently approved for the treatment of candidemia and invasive candidiasis in adults, with an ongoing Phase III study for the prophylaxis of IFD in adult patients undergoing allogeneic BMT.

Topline results of the Phase III study for REZZAYO are expected in Q2 2026. For more information visit:  or

POSITION:

The Key Account Manager (KAM) position is a hospital-based or integrated sites of care-based position focused on launching and selling innovative products in the assigned institutional accounts, including integrated delivery networks (IDNs) and alternate sites of care for infusion. The role includes educating clinicians on the clinical benefits of Cor Medix Therapeutics products to facilitate and gain improved institutional formulary access while expanding appropriate product utilization, through protocol adoption, to exceed business and customer objectives with assigned hospitals and IDNs.

The KAM also has accountability for pulling through contracts and facilitating account and clinician access opportunities to ensure achievement of Cor Medix Therapeutic's business goals. KAMs are required to follow the hospitalized patient journey and call Long Term Acute Care hospitals and home infusion companies if determined necessary in their territories. Some of the products will require the KAM to call on infusion centers outside the hospital, open sites of care outside of a hospital for infusion as well as call on customers that refer into those infusion centers.

This role will manage key accounts across the Arizona territory.

PRIMARY RESPONSIBILITIES:

* Increase product access and sales in the geographical area by navigating the institutional formulary approval process, as well as educating customers on appropriate use of Cor Medix Therapeutic products.

* Secure placement of Cor Medix Therapeutic's products on appropriate account protocols and ensure products are in the EMR systems.

* Develop relationships with local infusion sites, LTACH's and home infusion companies.

* Develop territory and account-level plans to grow product utilization, formulary access, and expand the customer base.

* Understand multiple interdependencies within an account, consider customer treatment goals and needs, and maximize account performance by aligning appropriate solutions, messaging, and stakeholders.

* Establish and maintain professional relationships with customer opinion leaders and hospitals, including physicians, medical staff and pharmacies.

* Plan, coordinate, and implement hospital-oriented education forums in accordance with company policies and business plans.

* Partner with hospital treatment committees to include Cor Medix Therapeutics products on appropriate disease state protocols.

* Facilitate continuity of care for discharging patients via Cor Medix Therapeutics product inclusion on discharge protocols/orders and alignment of approved Cor Medix Therapeutics reimbursement resources.

*…